WHO 'deeply concerned' over Covid vaccines approved for emergency use not being recognised in all countries: Official Addressing a press briefing, Dr Bruce Aylward, Senior Advisor to WHO Director General Dr Tedros Adhanom Ghebreyesus, said the organisation again calls on “all countries to ensure the recognition of vaccines proven to be efficacious and safe and certainly that meet WHO Emergency Use Listing criteria”. https://ift.tt/eA8V8J
SEC set to review Covaxin trial data for use in children Bharat Biotech has completed the Phase 2/3 trials of COVID-19 vaccine Covaxin for use in children under 18 years of age. https://ift.tt/eA8V8J
After tit for tat, UK recognises SII vax, junks its ‘Q’ order From October 11, Indians who have been fully vaccinated with WHO-approved Covishield will not be required to undergo the mandatory 10-day quarantine on arrival in the UK, ending a standoff between the two countries. https://ift.tt/eA8V8J